The following articles are included in the special issue of JCTS, Re-engineering the Clinical Research Enterprise in Response to COVID-19: The CTSA Experience. Four members of the CCTS team are authors, each in bold below. This email address is being protected from spambots. You need JavaScript enabled to view it. to learn more about any of the research topics explored in this special issue.

     Re-engineering The Clinical Research Enterprise in Response to COVID-19: The Clinical Translational Science Award (CTSA) experience and proposed playbook for future pandemics: Barry S. Coller, John B. Buse, Robert P. Kimberly, Director of the CCTS, William G. Powderly, Martin S. Zand

     Building biorepositories in the midst of a pandemic: Jennifer A. Croker, Senior Administrator Director of the CCTS, Robin Patel, Kenneth S. Campbell, Marietta Barton-Baxter, Shannon Wallet, Gary S. Firestein, Robert P. Kimberly, Director of the CCTS, Olivier Elemento

     Research Informatics and the COVID-19 Pandemic: Challenges, Innovations, Lessons Learned, and Recommendations: Richard J. Bookman, James J. Cimino, Director of CCTS Informatics, Christopher A Harle, Rhonda G. Kost, Sean Mooney, Emily Pfaff, Svetlana Rojevsky, Jonathan N. Tobin, Adam Wilcox, Nick F. Tsinoremas

     Challenges and Lessons Learned for Institutional Review Board Procedures During the COVID-19 Pandemic: Daniel E Ford, Ann Johnson, Jason J Nichols, Director of CCTS Network Capacities, Erin Rothwell, Steve Dubinett, Arash Naiem